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Abstract
Background Diabetic Foot Ulceration in patients with diabetes could be associated with high plantar pressure caused by diabetes
neuropathy. Therefore, it seems that one of the ways of identifying high-risk legs in diabetic patients with neuropathy would be
characterization of elevated plantar pressure distributions.
Objective Comparing the plantar pressure distribution in diabetic patients who suffered neuropathy with those without neuropathy.
Methods and materials Plantar pressure distribution was recorded in the following categories: 38 diabetic patients without
neuropathy, 30, 40 and 34 patients with mild neuropathy, moderate and severe neuropathy respectively.
Results Patients suffered from severe neuropathy suggested higher maximum peak plantar pressure at midfoot, heel, and medial
forefoot. The peak pressure of midfoot was significantly different in the following categories as well: patient without neuropathy
(32.3 ± 17.9 kPa), mild neuropathic (24.0 ± 17.9 kPa), moderate neuropathic (21.5 ± 12.6 kPa), and severe neuropathic (22.9 ±
10.7 kPa) groups (p = 0.02).
Conclusion The progression of diabetic neuropathy would have been increased followed by the peak plantar pressure.
Keywords Biomechanics . Diabetesmellitus . Neuropathy . Plantar pressure
Introduction
It is estimated that in 2030 the number of patients with diabetes
worldwide will exceed 365 million [1]. Cardiovascular disease,
neuropathy, nephropathy, and retinopathy are among various
complications of diabetes mellitus. Peripheral neuropathy is a
leading cause of morbidity in these patients. With increase in
the prevalence of obesity and associated diabetes mellitus, the
frequency of symptomatic diabetic neuropathy is growing. It is
believed that about 50% of patients with diabetes will have
diabetic peripheral neuropathy in 10 to 15 years [2]. The prev-
alence of diabetic neuropathy is also increased with poor dia-
betes control [3–5]. Patients with diabetes mellitus 1 may also
suffer from severe diabetic neuropathy in the first years after
diagnosis if their blood sugar is poorly controlled [6].
In the course of peripheral neuropathy, peripheral nerves
are progressively degenerated especially in inferior extremi-
ties, which can lead to motor and sensory deficits affecting
biomechanics of diabetic foot. One of these effects is on the
plantar pressure distribution [7–9], which in combination with
sensory defect are mainly responsible for development of ul-
cer in patients with diabetic neuropathy [2, 10]. Changes in
ankle [2, 11, 12] and gait kinetics [13–15] are other conse-
quences of diabetic neuropathy. Previous studies showed that
increased plantar pressure in patients with diabetic neuropathy
is related to foot ulceration [16–23], although some authors
failed to show increased peak plantar pressure in patients with
diabetic foot ulcer [24]. However, no study has evaluated
plantar pressures in patients with different stages of neuropa-
thy but without ulceration. Since worsening neuropathy could
be a predictive of diabetic ulcer development study; the aim of
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this study was to investigate the distribution of plantar pres-
sure in three groups of patients with different stages of neu-
ropathy and to compare them with a control group of diabetic
patients without neuropathy.
Methods and materials
After ethics committee approval, this cross-sectional study
was carried out between November 2014 and June 2016 in
Shariati Hospital, a university hospital in Tehran, Iran.
Study population and design Patients with diabetes
mellitus type 2 with or without peripheral neuropathy
presenting to the Diabetes Clinic of Shariati Hospital
were assessed for eligibility. The diagnosis of diabetes
mellitus was made by reviewing medical records of pa-
tients and those between the ages 30 and 60 years with a
history of more than 2 years since diagnosis of diabetes
were enrolled into the study after obtaining informed
consent about the study procedure. The exclusion criteria
were the ages younger than 30 and older than 60 years,
use of any kind of walking assist devices, history of foot
ulcer or present ulcer, Charcot arthropathy confirmed by
radiography, lower limb amputation, and use of medi-
cines for treatment of neuropathy.
According to a study by Bacarin et al. [18], entitled
Bdistribution of plantar pressure during walking in diabetic
patients suffering neuropathy, considering α = 05.05, β =
0.02, SD1 = 78/4, SD2 = 118/5, d = 60 and regarding to the
following formula, the sample size in each group was estimat-




SD1 þ SD2ð Þ2
d2
¼ 20
In our study, the minimum number of samples in each
group was 30 patients.
Subject selection was continued until the desired sample
size was achieved. Total number of 71 patients enrolled into
the study was divided into 4 groups: diabetic control patients
without neuropathy (DC, n = 38), with mild neuropathy (Mi,
n = 30), moderate neuropathy (Mo, n = 40), and severe neu-
ropathy (S, n = 34) (Table 1). The diabetic control group was
consisted of patients who were matched with neuropathic pa-
tients for anthropometric characteristic such as weight, body
mass index, and age. Michigan Neuropathy Screening
Instrument questionnaire (MNSI-q) was used for allocation
of patients into the study groups. MNSI consists of two parts.
The first part was related to the patient’s history including 15
self-administered questions on foot sensation. The second part
was a following brief physical assessment which completed
by health professionals: feet inspection (for deformities, dry
skin, hair or nail abnormalities, callous or infection), vibration
sensation screening at the dorsum of the great toe, ankle re-
flexes grading and monofilament testing.
Study procedure Data collection began with anthropometric
and demographic data and information on duration of the dis-
ease. All the clinical examinations were performed by a single
examiner to preserve consistency and repeatability and to
avoid inter-observational variations. All the patients were then
asked to answer the MNSI-q, which includes questions about
common sensory symptoms of diabetic neuropathy. …..Plain
radiographs of foot were obtained from all subjects and
reviewed by an expert radiologist to ensure absence of
Charcot arthropathy.
Plantar pressure distribution was assessed using Foot
Pressure SN GP MultiSence 4–2008-703 (Gebiom mbH
munster). First, subjects stood on the device with barefoot to
measure overall status of plantar pressure in a static fashion.
Then, dynamic pressures were measured for both feet by
instructing the patients to walk on the surface of the device.
Peak plantar pressures in different areas of foot were then
recorded. We divided the plantar surface into 5 areas: heel,
midfoot, lateral forefoot, medial forfoot, and hallux (Fig. 1).
Before executing measurements, the subjects walked freely
in the department in order to reproduce their typical gait for
about 3 min. Several training runs were performed to famil-
iarize subjects with the system.
Statistical analysis IBM SPSS statistical software version 21
was used for the statistical analysis. Means and percentages
Table 1 Demographic features of
study population No neuropathy Mild neuropathy Moderate neuropathy Severe neuropathy
n 38 30 40 34
Age (years) 53.8 ± 8.5 52.7 ± 6.6 54.0 ± 6.8 54.4 ± 8.0
M/F (% male) 24/14 (63.2%) 20/10 (66.7%) 14/26 (35.0%) 16/18 (47.1%)
BMI (kg/m2) 27.0 ± 4.4 27.7 ± 3.2 28.0 ± 4.0 27.2 ± 5.8
Diabetes duration (years) 5.7 ± 2.9 7.6 ± 6.9 8.2 ± 5.0 10.8 ± 5.7*
Data are means ± SD, unless otherwise indicated. *P < 0.001 vs non-neuropathic group (Bonferroni method)
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were used to describe data. Distribution of data was evaluated
by Kolmogrov-Smrinov test. For parametrically distributed da-
ta, one-way ANOVAwas used followed by the Sheffer’s Post
Hoc test. Moreover Fischer’s exact test used to identify differ-
ences among the various groups. Kruskal-Wallis test was used
for non-parametrically distributed data. In the current study, the
first type errors less than 0.05 were considered acceptable.
Results
The demographic features of study population are summa-
rized in Table 1. The group with severe neuropathy had a
longer duration of diabetes than their counterparts with no
neuropathy. No statistically significant differences were found
regarding other features between study groups.
The peak plantar pressures are shown in Table 2. Peak
pressure was significantly different between severe neuropath-
ic group versus other groups for the midfoot (p < 0.05). Severe
neuropathy group had higher values than diabetic patients
without neuropathy in 3 of 5 areas: heel, midfoot, and medial
forefoot (p < 0.05). In lateral forefoot, no difference was found
among different groups. Figure 2 shows boxplot graphs of
peak plantar pressure in diabetic patients without and with
mild, moderate, and severe neuropathy.
Discussion
The combination of high plantar pressure and sensory defect is
responsible for development of ulcer in diabetic patients with
neuropathy [2, 10]. Increased plantar pressure is described in
neuropathic patients and has been showed to be related with
foot ulcer [16, 17, 22]. Most studies describing foot pressure
point towards peak plantar pressures without indicating the
area under which pressure is measured. Many studies report
peak plantar pressures in anterior region of foot, because neu-
ropathic ulcers commonly occur in the area. Moreover, previ-
ous studies have not evaluated plantar pressures in diabetic
patients with different stages of neuropathy yet without foot
ulcer [16, 17, 21, 22, 25, 26].
Sensory defect, foot deformities, decreased joint mobility,
presence of callus and decreased thickness of plantar tissue
have been related to high plantar pressure [9, 27–29]. Proper
foot design for reducing increased plantar pressure is an active
area of research [30, 31]. The knowledge about different af-
fecting variables including plantar pressure is necessary to
achieve the best design in order to reduce probability of foot
ulcer formation [32]. Considering the limitations of previous
studies, the current study aims to evaluate peak plantar pres-
sures for different areas of plantar surface in diabetic patients
without and with mild, moderate, and severe neuropathy.
For the heel and medial forefoot areas, peak plantar pres-
sures in severe neuropathic group was higher than non-
Fig. 1 Areas of palmar surface: heel (27% of foot length), midfoot (28%
of foot length), lateral forefoot (65% of foot width), medial forfoot (35%
of foot width), and hallux (final 20% of length with 33% of foot width)
Table 2 Peak plantar pressure
(kPa) No neuropathy Mild neuropathy Moderate neuropathy Severe neuropathy
Heel 16.8 ± 8.5 18.0 ± 11.8 16.9 ± 5.5 23.5 ± 8.2*‡
Midfoot 7.8 ± 4.2 8.2 ± 5.3 10.8 ± 6.2 18.3 ± 19.0*†‡
Lat. forefoot 17.5 ± 13.4 18.6 ± 13.4 15.1 ± 8.6 19.0 ± 13.4
Med. forefoot 23.0 ± 12.6 20.7 ± 9.7 25.1 ± 11.0 12.1 ± 25.8*†
Hallux 32.3 ± 17.9 24.0 ± 17.9* 21.5 ± 12.6 22.9 ± 10.7
Data are means ± SD. *P < 0.05 vs non-neuropathic group, †P < 0.05 vs mild neuropathy group, ‡P < 0.05 vs
moderate neuropathy group (Bonferroni method)
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neuropathic and mild neuropathic groups in the current study.
The most significant differences among groups were found in
the midfoot. In this area, severe neuropathy group had higher
pressures than other groups of study. Interestingly, for the
hallux area, plantar pressure was higher in non-neuropathic
group than moderate neuropathy group. There was no
significant difference regarding peak plantar pressure for lat-
eral forefoot area.
The results of studies about plantar pressures are so dif-
ferent. The reasons for this variability includes how partici-
pating patients were selected regarding disease severity, pres-
ence or absence of peripheral neuropathy, history of foot
Fig. 2 Peak plantar pressure in diabetic patients without and with mild, moderate, and severe neuropathy for different areas of palmar surface: a heel, b
midfoot, c medial forefoot, d lateral forefoot, and e hallux
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ulcer, and the tool used for investigations. In 2002, Caselli
et al. [20] showed that patients with diabetic neuropathy had
higher plantar pressures than non-neuropathic patients with
diabetes in both anterior and posterior areas of plantar sur-
face. Later, some studies found that in patients with diabetic
neuropathy the point of the maximum plantar pressure is
matched with the maximum stress entered in inferior surface
of foot in just 20% of occasions [33].
The results of a study carried out by Bacarin et al. [18]
showed that plantar pressure in the group with neuropathy
but without ulcer is higher than diabetic controls without neu-
ropathy for the midfoot and rearfoot areas. The most signifi-
cant difference was for the midfoot, a result that has been
confirmed by our study. Charcot arthropathy in neuropathic
patients has been ruled out from the current study and absence
of the condition was confirmed by performing plain radiogra-
phies. Thus, higher peak pressures for the midfoot in patients
with more severe neuropathy cannot be associated with
Charcot condition or longitudinal arch descend in neuropathic
patients. The explanation for higher plantar pressure in this
area can be made by loading pattern shift from lateral part of
the foot to more medial parts, which is more obvious in pa-
tients with more severe neuropathy [34]. In the study per-
formed by Sinacore et al. [35], authors found changes in plan-
tar pressure of the midfoot in patients with neuropathy. They
suggested the possibility of presence of polymorphisms not
detectable with plain radiographs which can lead to increased
load under the midfoot [35].
Under the hallux, more severe neuropathy groups showed
no higher peak pressures than less severe neuropathy groups,
but surprisingly, patients without neuropathy had higher pres-
sures than moderate neuropathy group. Bacarin et al. [18]
found that in the hallux area, there was no difference between
diabetic controls, non-neuropathics and patients with diabetic
foot ulcer regarding both peak pressure and pressure-time in-
tegral. The authors showed the less differences among groups
in the area [18]. In our study, the less differences among
groups was also found in 2 areas: hallux and lateral forefoot.
Neuromuscular compensatory mechanisms that develop in
neuropathic patients to compensate their sensory deficit lead
to changes in roll-over mechanisms of foot [36]. Fang et al.
[37] suggested that peripheral neuropathy plays an important
role in the disturbance of plantar pressure distribution in pa-
tients with diabetic foot. Presence of abnormality in foot phys-
ical features due to neuropathy is associated with disorder of
sensory conduction of sural nerve, motor conduction of com-
mon peroneal nerve, and involvement of extensor muscles.
Reversely, it can be stated that disturbance of plantar pressure
distribution is an indicator of development of neuropathic dis-
order in patients with diabetes [37]. Syed et al. [38] also
showed that in the absence of neuropathy, there is no signifi-
cant difference regarding plantar pressures between patients
with diabetes and healthy controls.
Age, duration of diabetes, increased blood sugar, retinopa-
thy and history of plantar ulcer are among risk factors for
formation of peripheral neuropathy [39]. The prevalence and
pattern of peripheral neuropathy is different in various coun-
tries and varies from 1.5 to 100% in patients with type 2
diabetes mellitus. In general, there is a positive and direct
relationship between the severity of peripheral neuropathy
and duration of DM type 2 [40]. Although there was no sta-
tistically significant difference among study groups, but the
means for diabetes duration were higher in patients with more
severe neuropathy. It’s known for years that diabetic neurop-
athy is a chronic outcome of diabetes mellitus and the risk of
ulcer formation increases with time [2].
In our study, no significant difference was found among the
groups regarding body mass index. Previous studies showed
higher body mass indices in diabetic patients with neuropathy
than non-neuropathic controls [20]. Shen et al. [41] reported
that each unit increase in body mass index of patients with
diabetes leads to 5.96 kPa increase of plantar pressure. Ethnic
differences can be the probable explanation for dissimilarity of
previous studies with the current study.
It is important to point out other factors that can interfere
with plantar pressure distribution. These factors include foot
deformities [7] and movements of foot and ankle joint com-
plex [9, 21, 42]. Diabetic neuropathy leads to progressive
changes in muscular trophism, especially in foot and ankle
intrinsic muscles, increase in joint rigidity, and changes in
collagenous structures in fasciae and tendons due to cross-
connection and non-enzymatic glycosylation of creatine.
This means that the structures of muscles, cartilages, tendons,
and ligaments are being altered which results in limitations of
foot mobility [9, 42, 43]. The study did not evaluate factors
related to join mobility. Although, we excluded subjects with
obvious foot deformity or Charcot arthropathy confirmed by
readiographs. Moreover, studies regarding the relationship be-
tween less passive or dynamic range of motion of foot joint
and higher plantar pressure are not so clear. In a study carried
out by Turner et al. [44] the author showed that despite sig-
nificant decrease in passive range of motion of ankle joint
complex in diabetic patients, the range of motion at the time
of walking in patients with diabetes is not distinguishable
from healthy subjects and was not related to the plantar pres-
sure parameters [44].
We only used peak plantar pressures to compare different
groups regardless of measuring pressure-time integral. The
reason was as follows: first, assessment of pressure-time inte-
gral was not feasible with the system used in our study; sec-
ond, Waaijman et al. [45] investigated the correlation between
the variables peak plantar pressure and pressure-time integral
in diabetic patients with different footwear and showed that
the 2 parameters are directly correlated in common areas for
development of diabetic foot ulcer. They also reported that
peak plantar pressure is clinically more relevant parameter
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and value of reporting pressure-time integral added to peak
pressure is low.
Conclusion
Our investigations showed that groups with more severe neu-
ropathy had different plantar pressure distribution than less
severe neuropathy groups. The peak plantar pressures were
higher in the midfoot, heel, and medial forefoot areas in pa-
tients with severe neuropathy and the most significant differ-
ences among groups were seen in the midfoot. Evaluation of
plantar pressure in patients with diabetic neuropathy is of im-
portance and the results of such assessments can lead to the
detection of points at risk for development of ulcer in the
plantar surface of foot to take proper measures for preventing
ulcer formation.
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